Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Blood|December 26, 2008
B7-H4-deficient mice display augmented neutrophil-mediated innate immunityGefeng Zhu, Mathew M Augustine, Takeshi Azuma, et al.
Blood|September 21, 2012
Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cellsEric F Tewalt, Jarish N Cohen, Sherin J Rouhani, et al.
Nature Communications|June 21, 2013
B7-H5 costimulates human T cells via CD28HYuwen Zhu, Sheng Yao, Bettina P Iliopoulou, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2019
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell ImmunityYichen Chen, Jun Wang, Xi Wang, et al.
Blood|March 30, 2007
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cellsMonica V Goldberg, Charles H Maris, Edward L Hipkiss, et al.
The Journal of Investigative Dermatology|February 2, 2016
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient PrognosisNicolas Jacquelot, María Paula Roberti, David P Enot, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2010
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responsesPei-Yi Lin, Lishi Sun, Suzanne R Thibodeaux, et al.
Blood|December 26, 2008
B7-H4-deficient mice display augmented neutrophil-mediated innate immunityGefeng Zhu, Mathew M Augustine, Takeshi Azuma, et al.
Blood|September 21, 2012
Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cellsEric F Tewalt, Jarish N Cohen, Sherin J Rouhani, et al.
Nature Communications|June 21, 2013
B7-H5 costimulates human T cells via CD28HYuwen Zhu, Sheng Yao, Bettina P Iliopoulou, et al.
Journal for Immunotherapy of Cancer|March 3, 2022
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapiesJavier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2019
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell ImmunityYichen Chen, Jun Wang, Xi Wang, et al.
Blood|March 30, 2007
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cellsMonica V Goldberg, Charles H Maris, Edward L Hipkiss, et al.
The Journal of Investigative Dermatology|February 2, 2016
Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient PrognosisNicolas Jacquelot, María Paula Roberti, David P Enot, et al.
Pageof 29